Heron Therapeutics: Q1 Paints A Potentially Rosy Picture For 2025
…
1,872€
-5,02%
Echtzeit-Aktienkurs Heron Therapeutics Inc.
Bid:
Ask:
Nachrichten zur Heron Therapeutics Inc. Aktie
Heron Therapeutics, Inc. 2025 Q1 - Results - Earnings Call Presentation
…
Heron Therapeutics (HRTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Heron Therapeutics (HRTX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming…
Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics
Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics are part of the Zacks Industry Outlook article.…
Heron Therapeutics: Four Horse Race Of Approved Therapies
…
Heron Therapeutics: Approved Therapy With Blockbuster Potential But Meager Revenues
…
Heron Therapeutics, Inc. (HRTX) Q3 2024 Earnings Call Transcript
…
CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer
SOUTH SAN FRANCISCO, Calif, Oct. 02, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an…
Heron Therapeutics, Inc., (HRTX) Q2 2024 Earnings Call Transcript
…
Heron Therapeutics, Inc. 2024 Q2 - Results - Earnings Call Presentation
…
Heron Therapeutics: Opioid-Free Surgical Pain Relief Maven With Low Cash Reserves
…
CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236
Company continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA…
Earnings call: Heron Therapeutics reports revenue growth in Q1 2024 By Investing.com
Earnings call: Heron Therapeutics reports revenue growth in Q1 2024…
Heron Therapeutics, Inc. 2024 Q1 - Results - Earnings Call Presentation
…
Heron Therapeutics, Inc. (HRTX) Q1 2024 Earnings Call Transcript
…
Heron Therapeutics: Zynrelef Potentially Eases Shareholder Pain
…
Heron Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation
…
Heron Therapeutics, Inc. (HRTX) Q4 2023 Earnings Call Transcript
…